Young Ho Moon

Title: Young Ho Moon: Innovator in Pharmaceutical Chemistry

Introduction

Young Ho Moon is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific cancer-related pathways. With a total of 8 patents to his name, Moon's work is characterized by innovative methods that enhance the efficiency of drug production.

Latest Patents

Among his latest patents, Moon has developed a process for preparing thienopyrimidine compounds. This invention focuses on a novel method that selectively inhibits tyrosine kinase, specifically targeting the mutant epidermal growth factor receptor tyrosine kinase. The method allows for the industrial mass production of therapeutic agents for non-small cell lung cancer, making the process more convenient and efficient than traditional technologies. Another notable patent involves a method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one. This invention simplifies the preparation process by utilizing an inert polar protic solvent in the presence of a base, improving upon conventional methods.

Career Highlights

Young Ho Moon has worked with reputable companies in the pharmaceutical industry, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Throughout his career, Moon has collaborated with notable colleagues, including Gwan Sun Lee and Moon Sub Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Young Ho Moon's contributions to pharmaceutical chemistry are marked by his innovative patents and collaborative efforts. His work continues to impact the field, particularly in the development of targeted cancer therapies.